The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 28, 2021

Filed:

Jul. 12, 2019
Applicants:

Michael J Powell, Alamo, CA (US);

Aiguo Zhang, San Ramon, CA (US);

Michael Y Sha, Castro Valley, CA (US);

KE Zhan, San Mateo, CA (US);

Inventors:

Michael J Powell, Alamo, CA (US);

Aiguo Zhang, San Ramon, CA (US);

Michael Y Sha, Castro Valley, CA (US);

Ke Zhan, San Mateo, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6858 (2018.01); C12Q 1/6874 (2018.01); C40B 40/06 (2006.01); C12Q 1/6827 (2018.01); C12Q 1/686 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6858 (2013.01); C12Q 1/686 (2013.01); C12Q 1/6827 (2013.01); C12Q 1/6874 (2013.01); C40B 40/06 (2013.01); C12Q 2525/101 (2013.01); C12Q 2525/185 (2013.01); C12Q 2527/107 (2013.01); C12Q 2527/113 (2013.01); C12Q 2531/113 (2013.01);
Abstract

The invention relates to a method for enriching a target polynucleotide sequence containing a genetic variation said method comprising: (a) providing two primers targeted to said target polynucleotide sequence; (b) providing a target specific xenonucleic acid clamp oligomer specific for a wildtype polynucleotide sequence; (c) generating multiple amplicons using PCR under specific temperature cycling conditions; and (d) detecting said amplicons. We introduce a novel molecule, Xenonucleic Acid (XNA) for the NGS library preparation. XNA is able to selectively suppress amplification of DNA with wild type alleles and amplify DNA containing mutant alleles. Mutants with low allelic frequency will be easily detectable without deep sequencing after enrichment by adding XNA in multiplex PCR. The 17 actionable mutants related to lung or colorectal cancer diseases at different variant allelic frequency (VAF) % were investigated. Clinical sensitivity is significantly improved with XNA in various types of samples.


Find Patent Forward Citations

Loading…